US Patent

US10335502 — Freeze-dried formulation for gas-filled microvesicles

Formulation · Assigned to Bracco Suisse SA · Expires 2038-07-06 · 12y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a freeze-dried powder composition suitable for preparing gas-filled microvesicles, containing a phospholipid and a polyethylene glycol with 40% or higher folded polymeric chains.

USPTO Abstract

A freeze-dried powder composition comprising a phospholipid and a polyethylene glycol, said polyethylene glycol having a percentage of folded polymeric chains of 40% or higher. The composition is suitable for preparing gas-filled microvesicles.

Drugs covered by this patent

sulfur-hexafluoride-lipid-type-a-microspheres (Sulfur hexafluoride lipid-type A microspheres) · Children's Hospital of Philadelphia

Patent Metadata

Patent number: US10335502
Jurisdiction: US
Classification: Formulation
Expires: 2038-07-06
Drug substance claim: No
Drug product claim: Yes
Assignee: Bracco Suisse SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.